Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Sudden death
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Lymphoma
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021553628
Write-up: Sudden death; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number BE-FAMHP-DHH-N2021-91435. An adult male patient received first dose of bnt162b2 (COMIRNATY), on 08May2021 as 1st dose, single for covid-19 immunisation. Medical history included lymphoma. The patient''s concomitant medications were not reported. The patient experienced sudden death on 08May2021. No treatment received. The patient died on 08May2021. An autopsy was not performed. Reporter Comment: The patient died suddenly on this date. I happened to note when filling out the death certificates that he was prioritized for vaccination the same day with the first dose of Comirnaty. According to the family, the patient was recovering from lymphoma, with no active treatment at this time. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reporter''s Comments: The patient died suddenly on this date. I happened to note when filling out the death certificates that he was prioritized for vaccination the same day with the first dose of Comirnaty. According to the family, the patient was recovering from lymphoma, with no active treatment at this time.; Sender''s Comments: Information provided was so limited to prevent a meaningful or definite medical assessment for this demise. A causal relationship cannot be completely excluded between BNT162B2 injection and sudden death, due to the close chronological sequence. This case will be reassessed should additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Sudden death
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166